Saxenda and Infusion related reaction - a phase IV clinical study of FDA data

Summary:

Infusion related reaction is reported as a side effect among people who take Saxenda (liraglutide recombinant), especially for people who are female, 30-39 old, also take Ocrevus, and have Relapsing-remitting multiple sclerosis.

The phase IV clinical study analyzes which people have Infusion related reaction when taking Saxenda. It is created by eHealthMe based on reports of 6,333 people who have side effects when taking Saxenda from the FDA, and is updated regularly.

What is Saxenda?

Saxenda has active ingredients of liraglutide recombinant. It is often used in weight loss. eHealthMe is studying from 6,735 Saxenda users. Check the latest studies of Saxenda.

What is Infusion related reaction?

Infusion related reaction is found to be associated with 1,530 drugs and 1,353 conditions by eHealthMe. Check the latest studies of Infusion related reaction.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

6,333 people reported to have side effects when taking Saxenda.
Among them, 24 people (0.38%) have Infusion related reaction.

Could Saxenda cause Infusion related reaction?

Among these 24 people:

What is the gender of people who have Infusion related reaction when taking Saxenda? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Infusion related reaction when taking Saxenda? *

What are other drugs people take besides Saxenda? *

Benadryl: 19 people, 79.17%
Ocrevus: 19 people, 79.17%
Acetaminophen: 16 people, 66.67%
Methylprednisolone: 16 people, 66.67%
Synthroid: 11 people, 45.83%
Singulair: 9 people, 37.50%
Cetirizine Hydrochloride: 8 people, 33.33%
Omega 3: 7 people, 29.17%
Contrave: 7 people, 29.17%
Cymbalta: 6 people, 25.00%

What are other side effects people have besides Infusion related reaction? *

Fatigue (feeling of tiredness): 17 people, 70.83%
Nasopharyngitis (inflammation of the nasopharynx): 13 people, 54.17%
Hot Flush (sudden feelings of heat): 11 people, 45.83%
Rashes (redness): 11 people, 45.83%
Headache (pain in head): 11 people, 45.83%
The Flu (the flu is caused by an influenza virus): 8 people, 33.33%
Stress And Anxiety: 8 people, 33.33%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 8 people, 33.33%
Sinusitis (inflammation of sinus): 8 people, 33.33%
Facial Pain: 7 people, 29.17%

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 19 people, 79.17%
Weight Decreased: 10 people, 41.67%
Pain: 4 people, 16.67%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 16.67%
Depression: 4 people, 16.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 8.33%
Immunodeficiency Common Variable: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Saxenda and have Infusion related reaction?

- Check whether Infusion related reaction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Saxenda:

Saxenda (6,735 reports)

Browse all side effects of Saxenda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Infusion related reaction:

Infusion related reaction (1,530 drugs)

Browse all the conditions that are associated with Infusion related reaction:

Infusion related reaction (1,353 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on liraglutide recombinant (the active ingredients of Saxenda) and Saxenda (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.